Literature DB >> 14753745

The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.

Guy Eelen1, Lieve Verlinden, Mark van Camp, Paul van Hummelen, Kathleen Marchal, Bart de Moor, Chantal Mathieu, Geert Carmeliet, Roger Bouillon, Annemieke Verstuyf.   

Abstract

UNLABELLED: To identify key genes in the antiproliferative action of 1,25(OH)2D3, MC3T3-E1 mouse osteoblasts were subjected to cDNA microarray analyses. Eleven E2F-driven DNA replication genes were downregulated by 1,25(OH)2D3. These results were confirmed by quantitative RT-PCR in different cell types, showing the general nature of this action of 1,25(OH)2D3.
INTRODUCTION: 1Alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3] has a potent antiproliferative action characterized by a blocked transition from the G1- to the S-phase of the cell cycle. This study aims to identify genes whose expression is markedly altered after 1,25(OH)2D3 treatment in parallel with or preceding the observed G1-arrest.
MATERIALS AND METHODS: The cDNA microarray technique was used, and the expression of approximately 4600 genes in MC3T3-E1 mouse osteoblasts was studied 6 and 12 h after treatment with 10(-8) M 1,25(OH)2D3. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analyses were performed on MC3T3-E1 cells and on wildtype and vitamin D receptor (VDR) knockout primary murine epidermal keratinocytes (VDRwt MEKs, VDR-/- MEKs) and murine mammary tumor cells (GR) to confirm the microarray data. RESULTS AND
CONCLUSIONS: After 12 h of treatment, in parallel with the 1,25(OH)2D3-induced G1 arrest, a particular set of DNA replication genes including a cell division cycle 6 homolog, a DNA polymerase alpha subunit, proliferating cell nuclear antigen, two DNA polymerase delta subunits, and flap-structure specific endonuclease 1, was downregulated at least 2-fold. These genes are known targets of the E2F family of transcription factors, which are probably the central mediators of this action of 1,25(OH)2D3. Indeed, as shown by transfection assays with an E2F reporter construct, 12- and 24-h treatment of MC3T3-E1 cells with 1,25(OH)2D3 reduced E2F activity by 49% and 73%, respectively. Quantitative RT-PCR analyses confirmed the downregulation of these DNA replication genes by 1,25(OH)2D3 in MC3T3-E1, GR, and VDRwt MEKs cells, but not in VDR-/- MEKs cells, showing that this 1,25(OH)2D3-driven antiproliferative action is of a general nature and depends on a functional VDR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14753745     DOI: 10.1359/JBMR.0301204

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

Review 2.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

3.  Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.

Authors:  Leonid Bartik; G Kerr Whitfield; Magdalena Kaczmarska; Christine L Lowmiller; Eric W Moffet; Julie K Furmick; Zachary Hernandez; Carol A Haussler; Mark R Haussler; Peter W Jurutka
Journal:  J Nutr Biochem       Date:  2010-02-12       Impact factor: 6.048

4.  Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone.

Authors:  Fahim Atif; Iqbal Sayeed; Tauheed Ishrat; Donald G Stein
Journal:  Mol Med       Date:  2009-06-26       Impact factor: 6.354

5.  Levels of 25-hydroxyvitamin D3, biochemical parameters and symptoms of depression and anxiety in healthy individuals.

Authors:  Gleicilaine A S Casseb; Gabriela Ambrósio; Ana Lúcia S Rodrigues; Manuella P Kaster
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

Review 6.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

Review 7.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

8.  Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats.

Authors:  Milos Cekic; Sarah M Cutler; Jacob W VanLandingham; Donald G Stein
Journal:  Neurobiol Aging       Date:  2009-05-30       Impact factor: 4.673

Review 9.  Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor.

Authors:  Carsten Carlberg; Moray J Campbell
Journal:  Steroids       Date:  2012-11-23       Impact factor: 2.668

Review 10.  Molecular actions of vitamin D contributing to cancer prevention.

Authors:  James C Fleet
Journal:  Mol Aspects Med       Date:  2008-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.